Determination of ramipril in pharmaceutical dosage forms by reversed-phase liquid chromatography

Asian Journal of Chemistry

Volumn 18, Issue 2, 2006, Pages 788-792

  Rao, K V S Prasada ^a   Kumari, K Vijaya ^a   Prakash, I Bhanu ^a   Prabhakar, G ^a,b   Begum, Jameelunnisa ^a,c  

^a ANDHRA UNIVERSITY   (India)

^b St Theresas College for Women ^*  (India)

^c Department of Chemistry   (India)

Author keywords

Dosage forms; Ramipril; Reverse phase HPLC

Indexed keywords

EID: 33645544384     PISSN: 09707077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. H.Y. Aboul-Enein and S.A. Bakr, Drug Dev. Ind. Pharm., 18, 1013 (1992).
2. H.Y. Abou-Enein and C. Thiffault, Anal. Lett., 24, 2217 (1991).
3. M. Ito, T. Kuriki, J. Goto and T. Namabara, J. Liq. Chromatogr., 13, 991 (1990).
4. S.S. Zarapaker and S.H. Rane, Indian Drugs, 37, 589 (2000).
5. D. Bonazzi, R. Gotti, V. Andrisano and V. Cavrini, J. Pharm. Biomed. Anal., 16, 431 (1997).
6. U.J. Dhorda and N.B. Shetkar, Indian Drugs, 36, 638 (1999).
7. A.A. Al-Majed, F. Belal and A.A. Al-Warthan, Spectrosc. Lett., 34, 211 (2001).
8. S.M. Blaih, H.H. Abdine, F.A. El-Yazbi and R.A. Shaalam, Spectrosc. Lett., 33, 91 (2000).
9. H.E. Abdellatef, M.M. Ayad and E.A. Taha, J. Pharm. Biomed. Anal., 16, 431 (1997).
10. D. Schmidt, A. Keller and Z. Fresenius, Anal. Chem., 320, 731 (1985).
11. M.M. Ayad, A.A. Shalaby, H.E. Abdellatef and M.M. Hosny, J. Pharm. Biomed. Anal., 28, 311 (2002).
12. H.G. Eckert, G. Muenscher, R. Oekonomopulos, H. Strecker and H. Urbach Wissmann, Arzneim-Forsch, 377, 788 (1985).
13. H.E. Abdellatef, M.M. Ayad and E.A. Taha, J. Pharm. Biomed. Anal., 3, 431 (1997).
14. M.B. Aleksic, D.G. Agbaba and D.M. Milojkovic-Opsenica, Chromatographia, 53, S-442 (2001).
15. P.R. Tiller, L.A. Romanyshyn and U.D. Neue, Anal. Bioanal. Chem., 377, 788 (2003).
16. Z.M. Zhu and A. Vachareau, J. Chromatogr. B, 377, 788 (2003).
17. International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use: Harmonized Tripartite Guideline on Validation of Analytical Procedures: Methodology, Recommended for Adoption on September 4 at the ICH Steering Committee, IFPMA, Switzerland.